Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00916409
Recruitment Status : Completed
First Posted : June 9, 2009
Last Update Posted : April 10, 2017
Sponsor:
Information provided by (Responsible Party):
NovoCure Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 2016
Actual Study Completion Date : March 2017
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):